Data as of Sep 29
| -0.09 / -4.33%|
The 2 analysts offering 12-month price forecasts for Neptune Technologies & Bioressources Inc have a median target of 7.58, with a high estimate of 8.36 and a low estimate of 6.80. The median estimate represents a +281.07% increase from the last price of 1.99.
The current consensus among 2 polled investment analysts is to Buy stock in Neptune Technologies & Bioressources Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.